Results 281 to 290 of about 1,590,210 (316)
Some of the next articles are maybe not open access.
Cardiovascular risks in spondyloarthritides
Current Opinion in Rheumatology, 2007Spondyloarthritides are associated with increased cardiovascular risks, which can only partly be explained by traditional risk factors. It is likely that the chronic inflammatory state is involved. In this review, novel findings regarding cardiac and vascular pathologies and potential overlapping mechanisms will be discussed.Cardiac pathologies in ...
Sylvia, Heeneman, Mat J A P, Daemen
openaire +2 more sources
Rosiglitazone and Cardiovascular Risk
New England Journal of Medicine, 2007In this issue of the Journal, Nissen and Wolski1 report the results of a meta-analysis of treatment trials of rosiglitazone, as compared either with other therapies for type 2 diabetes or with placebo. Eligible studies included randomized trials that lasted for at least 24 weeks.
Bruce M, Psaty, Curt D, Furberg
openaire +2 more sources
[Hyperglycemia and cardiovascular risk].
Giornale italiano di cardiologia (2006), 2011Coronary artery disease and type 2 diabetes are chronic diseases of substantial and growing prevalence. Although diabetes is a strong independent risk factor for cardiovascular events, this risk is not confined to glucose levels above the diagnostic threshold for diabetes. Rather, there is now a growing consensus that nondiabetic hyperglycemia measured
Bianchi C +2 more
openaire +2 more sources
The Consultant Pharmacist, 2006
A case on cardiovascular risk reduction is presented. Multiple cardiovascular risks (dyslipidemia, hypertension, and diabetes) are addressed. Management of the metabolic syndrome and appropriate testing for the newer cardiovascular marker, C-reactive protein, are also discussed.
openaire +2 more sources
A case on cardiovascular risk reduction is presented. Multiple cardiovascular risks (dyslipidemia, hypertension, and diabetes) are addressed. Management of the metabolic syndrome and appropriate testing for the newer cardiovascular marker, C-reactive protein, are also discussed.
openaire +2 more sources
Albuminuria and Cardiovascular Risk
Heart Failure Clinics, 2006Zvezdana, Bogojevic, George L, Bakris
openaire +2 more sources
Preeclampsia and cardiovascular risk.
Minerva ginecologica, 2012The association between preeclampsia and cardiovascular disease has been an increasing area of interest over the last years. Cardiovascular disease is the number one cause of death in women in the western world and more women than men die of heart disease each year. The most common pregnancy disorder is preeclampsia.
Hermes, W. +2 more
openaire +3 more sources
CARDIOVASCULAR RISK WITH NSAIDS
BJU International, 2012Makanjuola, Jonathan, Bultitude, Matthew
openaire +3 more sources
Cardiovascular risks in obesity
Journal of Endocrinological Investigation, 2002Uchegbu, EC, Kopelman, PG
openaire +2 more sources

